2-(cyclohexanecarboxamido)benzoic acid | 25437-73-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(cyclohexanecarboxamido)benzoic acid
• 英文别名: 2-[(Cyclohexylcarbonyl)amino]benzoic acid；2-(cyclohexanecarbonylamino)benzoic acid
• CAS: 25437-73-4
• 化学式: C₁₄H₁₇NO₃
• mdl: MFCD00223756
• 分子量: 247.294
• InChiKey: TVONCUQFOOJSCC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(cyclohexanecarboxamido)benzoic acid 在 乙酸酐 作用下， 生成 2-cyclohexyl-4H-benzo[d][1,3]oxazin-4-one
  参考文献：
  名称：

  Ruthenium(II) Catalyzed Regiospecific C–H/O–H Annulations of Directing Arenes via Weak Coordination

  摘要：

  Ruthenium(II) catalyzed oxidative CH/OH annulations have been demonstrated using two different directing arenes viz. 2-arylquinolinone and 2-arylbenzoxazinone with internal alkynes. Regiospecific annulations have been observed for both directing arenes via the assistance of weaker carbonyl oxygen in the presence of a stronger nitrogen-directing site. In this substrate-controlled convergent protocol the weaker directing group dictates the annulation path.

  DOI：

  10.1021/acs.orglett.5b02967
• 作为产物：
  描述：

  methyl 2-(cyclohexanecarboxamido)benzoate 在 水 、 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 1.0h， 以95%的产率得到2-(cyclohexanecarboxamido)benzoic acid
  参考文献：
  名称：

  MODULATORS OF THE RELAXIN RECEPTOR 1

  摘要：

  本文揭示了人类松弛素受体1的调节剂，例如，公式（I）中的A、R1和R2如本文所定义，这些调节剂在治疗哺乳动物松弛素受体1介导的人类健康方面，例如心血管疾病中是有用的。还公开了一种包含药用适宜载体和本公开的至少一种化合物的组合物，以及一种用于治疗介导人类松弛素受体1的哺乳动物健康方面的干预方法。

  公开号：

  US20150119426A1

文献信息

• [EN] THERMOPLASTIC POLYMER COMPOSITION<br/>[FR] COMPOSITION DE POLYMÈRE THERMOPLASTIQUE
  申请人：MILLIKEN & CO

  公开号：WO2015042561A1

  公开（公告）日：2015-03-26

  The invention provides a thermoplastic polymer composition comprising a polyolefin polymer and a nucleating agent. The nucleating agent comprises a compound conforming to the structure of Formula (I). The invention also provides a series of compounds encompassed by the structure of Formula (I).

  这项发明提供了一种热塑性聚合物组合物，包括聚烯烃聚合物和成核剂。该成核剂包括符合式(I)结构的化合物。该发明还提供了一系列符合式(I)结构的化合物。
• Silver-Mediated Synthesis of 4<i>H</i> -Benzoxazin-4-ones by Intramolecular Decarboxylative <i>O</i> -Acylation Reactions with α-Oxocarboxylic Acid
  作者：Kuppusamy Bharathimohan、Thanasekaran Ponpandian、Ahamed A. Jafar

  DOI：10.1002/ejoc.201700176

  日期：2017.5.18

  The first example of intramolecular decarboxylative acylation reaction with α-oxocarboxylic acid has been described. This method offers a mild and rapid synthesis of 4H-benzoxazin-4-ones derivatives in high yields with silver salt.

  已经描述了与α-氧代羧酸的分子内脱羧酰化反应的第一个实例。该方法可以用银盐温和快速地合成4H-苯并恶嗪-4-酮衍生物。
• Transcription factor modulating compounds and methods of use thereof
  申请人：Levy Stuart B.

  公开号：US20090131401A1

  公开（公告）日：2009-05-21

  Substituted benzoimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of making and using substituted benzoimidazole compounds, as well as pharmaceutical preparations thereof, in, e.g., reducing antibiotic resistance and inhibiting biofilms.

  本发明提供了可用作抗感染剂的取代苯并咪唑化合物，其可降低微生物的耐药性、毒力或生长。本发明还提供了制备和使用取代苯并咪唑化合物的方法，以及其制备的药物制剂，例如用于减少抗生素耐药性和抑制生物膜的制剂。
• Modulators of the relaxin receptor 1
  申请人：The United States of America, as Represented by the Secretary, Department of Health and Human Service

  公开号：US10125112B2

  公开（公告）日：2018-11-13

  Disclosed are modulators of the human relaxin receptor 1, for example, of formula (I), wherein A, R1, and R2 are as defined herein, that are useful in treating mammalian relaxin receptor 1 mediated facets of human health, e.g., cardiovascular disease. Also disclosed is a composition comprising a pharmaceutically suitable carrier and at least one compound of the disclosure, and a method for therapeutic intervention in a facet of mammalian health that is mediated by a human relaxin receptor 1.

  公开了人类松弛素受体1的调节剂，例如式（I），其中A、R1和R2如本文所定义，可用于治疗哺乳动物松弛素受体1介导的人类健康问题，例如心血管疾病。还公开了一种组合物，该组合物包含药学上合适的载体和至少一种本公开的化合物，以及一种治疗干预哺乳动物健康的方法，该哺乳动物的健康是由人类松弛素受体1介导的。
• Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain
  作者：Danielle McShan、Stefan Kathman、Brittiney Lowe、Ziyang Xu、Jennifer Zhan、Alexander Statsyuk、Ifedayo Victor Ogungbe

  DOI：10.1016/j.bmcl.2015.08.074

  日期：2015.10

  Rhodesain, the major cathepsin L-like cysteine protease in the protozoan Trypanosoma brucei rhodesiense, the causative agent of African sleeping sickness, is a well-validated drug target. In this work, we used a fragment-based approach to identify inhibitors of this cysteine protease, and identified inhibitors of T. brucei. To discover inhibitors active against rhodesain and T. brucei, we screened a library of covalent fragments against rhodesain and conducted preliminary SAR studies. We envision that in vitro enzymatic assays will further expand the use of the covalent tethering method, a simple fragment-based drug discovery technique to discover covalent drug leads. (C) 2015 Elsevier Ltd. All rights reserved.